Could your own cells fix Parkinson's? new trial begins
NCT ID NCT06778265
First seen Nov 18, 2025 · Last updated May 22, 2026 · Updated 20 times
Summary
This early study tests a new treatment called UX-DA001 for people with Parkinson's disease. The treatment uses a patient's own cells to create dopamine-producing brain cells, which are then transplanted into the brain. The main goal is to check if the procedure is safe, but researchers will also look for signs that it improves movement. The trial involves 12 people aged 50-75 who have had Parkinson's for 5-20 years and whose current medications are no longer working well.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE, IDIOPATHIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China
Conditions
Explore the condition pages connected to this study.